Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage

Journal of Comparative Neurology

Volumn 498, Issue 5, 2006, Pages 637-648

  Tran, Phu V ^a   Akana, Susan F ^a   Malkovska, Irena ^b   Dallman, Mary F ^a   Parada, Luis F ^b   Ingraham, Holly A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Brain derived neurotrophic factor (BDNF); Exon BDNF transcripts; SF 1; Sympathetic tone; Ventromedlal hypothalamus (VMH, VMN)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; STEROIDOGENIC FACTOR 1;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOARCHITECTURE; ENERGY BALANCE; EXON; GENE; GENE ACTIVATION; GENE DOSAGE; GENE EXPRESSION; HETEROZYGOTE; HOMEOSTASIS; HYPERPHAGIA; HYPOTHALAMUS FUNCTION; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; SF 1 GENE; SYMPATHETIC TONE; ZONA INCERTA;

ALPHA-MSH; ANIMALS; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; COLD; FOOD DEPRIVATION; GENE EXPRESSION; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; LEPTIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; OXYGEN CONSUMPTION; PROMOTER REGIONS (GENETICS); RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS; TRANSCRIPTION FACTORS; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 33748454310     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21070     Document Type: Article

References (47)

1. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, Gurakan B, Jameson JL. 2002. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 87:1829-1833.
2. Avrith D, Mogenson GJ. 1978. Reversible hyperphagia and obesity following intracerebral microinjections of colchicine into the ventromedial hypothalamus of the rat. Brain Res 153:99-107.
3. Ballarin M, Ernfors P, Lindefors N, Persson H. 1991. Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Exp Neurol 114:35-43.
4. Baskin DG, Seeley RJ, Kuijper JL, Lok S, Weigle DS, Erickson JC, Palmiter RD, Schwartz MW. 1998. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes 47:538-543.
5. Bennett JL, Zeiler SR, Jones KR. 1999. Patterned expression of BDNF and NT-3 in the retina and anterior segment of the developing mammalian eye. Invest Ophthalmol Vis Sci 40:2996-3005.
6. Bland ML, Fowkes RC, Ingraham HA. 2004. Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol Endocrinol 18:941-952.
7. Bland ML, Jamieson CA, Akana SF, Bornstein SR, Eisenhofer G, Dallman MF, Ingraham HA. 2000. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Natl Acad Sci U S A 97:14488-14493.
8. Buijs RM, Chun SJ, Niijima A, Romijn HJ, Nagai K. 2001. Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J Comp Neurol 431:405-423.
9. Canteras NS, Simerly RB, Swanson LW. 1994. Organization of projections from the ventromedial nucleus of the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J Comp Neurol 348:41-79.
10. Choi GB, Dong HW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Swanson LW, Anderson DJ. 2005. Lhx6 delineates a pathway mediating innate reproductive behaviors from the amygdala to the hypothalamus. Neuron 46:647-660.
11. Choi S, Dallman MF. 1999. Hypothalamic obesity: multiple routes mediated by loss of function in medial cell groups. Endocrinology 140:4081-4088.
12. Choi S, Horsley C, Aguila S, Dallman MF. 1996. The hypothalamic ventromedial nuclei couple activity in the hypothalamo-pituitary-adrenal axis to the morning fed or fasted state. J Neurosci 16:8170-8180.
13. Correa RV, Domenice S, Bingham NC, Billerbeck AE, Rainey WE, Parker KL, Mendonca BB. 2004. A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab 89:1767-1772.
14. Dallman MF, Akana SF, Bhatnagar S, Bell ME, Choi S, Chu A, Horsley C, Levin N, Meijer O, Soriano LR, Strack AM, Viau V. 1999. Starvation: early signals, sensors, and sequelae. Endocrinology 140:4015-4023.
15. Davis AM, Seney ML, Stallings NR, Zhao L, Parker KL, Tobet SA. 2004. Loss of steroidogenic factor 1 alters cellular topography in the mouse ventromedial nucleus of the hypothalamus. J Neurobiol 60:424-436.
16. Dellovade TL, Young M, Ross EP, Henderson R, Caron K, Parker K, Tobet SA. 2000. Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes. J Comp Neurol 423:579-589.
17. Guillin O, Griffon N, Diaz J, Le Foll B, Bezard E, Gross C, Lammers C, Stark H, Carroll P, Schwartz JC, Sokoloff P. 2004. Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. Int Rev Neurobiol 59:425-444.
18. Ikeda Y, Luo X, Abbud R, Nilson JH, Parker KL. 1995. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 9:478-486.
19. Inoue S, Campfield LA, Bray GA. 1977. Comparison of metabolic alterations in hypothalamic and high fat diet-induced obesity. Am J Physiol 233:R162-168.
20. Isackson PJ, Huntsman MM, Murray KD, Gall CM. 1991. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 6:937-948.
21. Kernie SG, Liebl DJ, Parada LF. 2000. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19:1290-1300.
22. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum JM, Madauss K, Montana V, Lebedeva L, Suzawa M, Williams JD, Williams SP, Guy RK, Thornton JW, Fletterick RJ, Willson TM, Ingraham HA. 2005. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343-355.
23. Li Y, Choi M, Cavey G, Daugherty J, Suino K, Kovach A, Bingham NC, Kliewer SA, Xu HE. 2005. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cells 17:491-502.
24. Majdic G, Young M, Gomez-Sanchez E, Anderson P, Szczepaniak LS, Dobbins RL, McGarry JD, Parker KL. 2002. Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 143:607-614.
25. Migliorini RH, Garofalo MA, Kettelhut IC. 1997. Increased sympathetic activity in rat white adipose tissue during prolonged fasting. Am J Physiol 272:R656-R661.
26. Morimoto A, Murakami N, Ono T, Watanabe T, Sakata Y. 1986. Stimulation of ventromedial hypothalamus induces cold defense responses in conscious rabbits. Am J Physiol 250:R560-R566.
27. Nakagawa T, Ogawa Y, Ebihara K, Yamanaka M, Tsuchida A, Taiji M, Noguchi H, Nakao K. 2003. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance. Int J Obes Relat Metab Disord 27:557-565.
28. Nef S, Parada LF. 1999. Cryptorchidism in mice mutant for Insl3. Nat Genet 22:295-299.
29. Niijima A, Rohner-Jeanrenaud F, Jeanrenaud B. 1984. Role of ventromedial hypothalamus on sympathetic efferents of brown adipose tissue. Am J Physiol 247:R650-R654.
30. Palou A, Pico C, Bonet ML, Oliver P. 1998. The uncoupling protein, thermogenin. Int J Biochem Cell Biol 30:7-11.
31. Pattabiraman PP, Tropea D, Chiaruttini C, Tongiorgi E, Cattaneo A, Domenici L. 2005. Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo. Mol Cell Neurosci 28:556-570.
32. Preston E, Triandafillou J, Haas N. 1989. Colchicine lesions of ventromedial hypothalamus: effects on regulatory thermogenesis in the rat. Pharmacol Biochem Behav 32:301-307.
33. Rahmouni K, Haynes WG, Morgan DA, Mark AL. 2003. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci 23:5998-6004.
34. Ricquier D, Bouillaud F, Toumelin P, Mory G, Bazin R, Arch J, Penicaud L. 1986. Expression of uncoupling protein mRNA in thermogenic or weakly thermogenic brown adipose tissue. Evidence for a rapid beta-adrenoreceptor- mediated and transcriptionally regulated step during activation of thermogenesis. J Biol Chem 261:13905-13910.
35. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM, Jaenisch R. 2001. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15:1748-1757.
36. Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, Ebihara K, Masuzaki H, Hosoda K, Yoshimasa Y, Nakao K. 1999. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48:1787-1793.
37. Satoh N, Ogawa Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Okazaki T, Tamaki M, Hayase M, Yoshimasa Y, Nishi S, Hosoda K, Nakao K. 1997. Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138:947-954.
38. Shimizu N, Oomura Y, Plata-Salaman CR, Morimoto M. 1987. Hyperphagia and obesity in rats with bilateral ibotenic acid-induced lesions of the ventromedial hypothalamic nucleus. Brain Res 416:153-156.
39. Shinoda K, Lei H, Yoshii H, Nomura M, Nagano M, Shiba H, Sasaki H, Osawa Y, Ninomiya Y, Niwa O, et al. 1995. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn 204:22-29.
40. Suga A, Hirano T, Kageyama H, Kashiba M, Oka J, Osaka T, Namba Y, Tsuji M, Miura M, Adachi M, Inoue S. 1999. Rapid increase in circulating leptin in ventromedial hypothalamus-lesioned rats: role of hyperinsulinemia and implication for upregulation mechanism. Diabetes 48:2034-2038.
41. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S. 2004. Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 25:77-107.
42. Tonra JR, Ono M, Liu X, Garcia K, Jackson C, Yancopoulos GD, Wiegand SJ, Wong V. 1999. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes 48:588-594.
43. Tran PV, Lee MB, Marin O, Xu B, Jones KR, Reichardt LF, Rubenstein JR, Ingraham HA. 2003. Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons. Mol Cell Neurosci 22:441-453.
44. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF. 2003. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6:736-742.
45. Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, Sivaramakrishnan S, O'Rahilly S, Farooqi IS. 2004. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 7:1187-1189.
46. Young JB, Landsberg L. 1980. Impaired suppression of sympathetic activity during fasting in the gold thioglucose-treated mouse. J Clin Invest 65:1086-1094.
47. Zhao L, Bakke M, Hanley NA, Majdic G, Stallings NR, Jeyasuria P, Parker KL. 2004. Tissue-specific knockouts of steroidogenic factor 1. Mol Cell Endocrinol 215:89-94.